American Diabetes Association (ADA) Conference, San Diego Effects of Long-term, Monthly Administration of the PCSK9 Inhibitor Evolocumab in Patients with Dysglycemia or Metabolic Syndrome
Robert R. Henry, Rury R. Holman, Robert P. Giugliano, Frederick J. Raal, David Sullivan, Nariman Honarpour, Patric Nelson, Mary Elliott, Thomas Liu, Scott M. Wasserman, Michael J. Koren
Diabetes Care 2014;63 supp 1:A157
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk
